In focus
Illumina to sequence genomes for 450,000-person Singapore precision medicine study
Illumina has been selected to provide whole-genome sequencing for the SG-INSIGHT study under Phase III of Singapore's National Precision Medicine programme, expected to include around 450,000 individuals. The company will perform the work at its Singapore genomics facility.
Read the story